effects of chromium and vitamin D supplements on hemosysteien in type 2 diabetes
Phase 3
- Conditions
- diabets.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20190610043852N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 96
Inclusion Criteria
Patients with type 2 diabetes for at least 5 years.
In the age range of 25-60 years
6 months before the onset of study did not change the hypoglycemic drugs and remained stable during study.
Exclusion Criteria
not inject insulin.
Does not have severe inflammatory disease, kidney disease, liver disease, parathyroid disease, hyper and hypothyroidism
didn't take any vitamin and mineral supplements 6 months prior to the study
Has no history of using anticonvulsants, steroids, and tobacco in the past 6 months.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Homocysteine. Timepoint: before intervention, after intervention. Method of measurement: HPLC.
- Secondary Outcome Measures
Name Time Method Weight. Timepoint: Before and after the interference. Method of measurement: scale.;Height. Timepoint: Before and after the interference. Method of measurement: metr.;Blood pressure. Timepoint: Before and after the interference. Method of measurement: pressure indicator.